Pigment Epithelial-Derived Factor (Pedf)-Triggered Lung Cancer Cell Apoptosis Relies on P53 Protein-Driven Fas Ligand (Fas-L) Up-Regulation and Fas Protein Cell Surface Translocation.

Lei Li,Ya-Chao Yao,Shu-Huan Fang,Cai-Qi Ma,Yi Cen,Zu-Min Xu,Zhi-Yu Dai,Cen Li,Shuai Li,Ting Zhang,Hong-Hai Hong,Wei-Wei Qi,Ti Zhou,Chao-Yang Li,Xia Yang,Guo-Quan Gao

DOI: https://doi.org/10.1074/jbc.m114.590000

2014-01-01

Abstract:Pigment epithelium-derived factor (PEDF), a potent antiangiogenesis agent, has recently attracted attention for targeting tumor cells in several types of tumors. However, less is known about the apoptosis-inducing effect of PEDF on human lung cancer cells and the underlying molecular events. Here we report that PEDF has a growth-suppressive and proapoptotic effect on lung cancer xenografts. Accordingly, in vitro, PEDF apparently induced apoptosis in A549 and Calu-3 cells, predominantly via the Fas-L/Fas death signaling pathway. Interestingly, A549 and Calu-3 cells are insensitive to the Fas-L/Fas apoptosis pathway because of the low level of cell surface Fas. Our results revealed that, in addition to the enhancement of Fas-L expression, PEDF increased the sensitivity of A549 and Calu-3 cells to Fas-L-mediated apoptosis by triggering the translocation of Fas protein to the plasma membrane in a p53- and FAP-1-dependent manner. Similarly, the up-regulation of Fas-L by PEDF was also mediated by p53. Furthermore, peroxisome proliferator-activated receptor γ was determined to be the upstream regulator of p53. Together, these findings uncover a novel mechanism of tumor cell apoptosis induced by PEDF and provide a potential therapeutic strategy for tumors that are insensitive to Fas-L/Fas-dependent apoptosis because of a low level of cell surface Fas.